| [1] |
Sakaguchi H, Nakanishi K, Kojima S. Inherited bone marrow failure syndromes in 2012[J]. Int J Hematol, 2013, 97(1): 20-9. doi: 10.1007/s12185-012-1249-9
|
| [2] |
Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway[J]. Nat Rev Cancer, 1994, 3(1): 51-2. http://cn.bing.com/academic/profile?id=82904f3e3d84ca634ca289474a948201&encoded=0&v=paper_preview&mkt=zh-cn
|
| [3] |
Alter BP. Cancer in fanconi anemia[J]. Cancer, 2003, 97(2): 425-40. doi: 10.1002/(ISSN)1097-0142
|
| [4] |
Alter BP, Giri N, Savage SA, et al. Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study[J]. Br J Haematol, 2010, 150(2):179-88. http://cn.bing.com/academic/profile?id=e08a0b2f86f5054c5d7cf46fee0be5ad&encoded=0&v=paper_preview&mkt=zh-cn
|
| [5] |
Joenje H, Patel KJ. The emerging genetic and molecular basis of fanconi anaemia[J]. Nat Rev Genet, 2001, 2(6): 446-57. doi: 10.1038/35076590
|
| [6] |
Dong H, Nebert DW, Bruford EA, et al. Update of the human and mouse fanconi anemia genes[J]. Human Genomics, 2015, 9(1):32-6. doi: 10.1186/s40246-015-0054-y
|
| [7] |
Schneider M, Chandler K, Tischkowitz M, et al. Fanconi anaemia: genetics,molecular biology,and cancer-implications for clinical management in children and adults[J]. Clin Genet, 2014, 88(1):13-24. http://cn.bing.com/academic/profile?id=209a5b760a1341557e5f52d0bdbe1eb3&encoded=0&v=paper_preview&mkt=zh-cn
|
| [8] |
Solomon PJ, Margaret P, Rajendran R, et al. A case report and literature review of Fanconi Anemia(FA) diagnosed by genetic testing[J]. Ital J Pediatr ,2015,4(1): 38-43. http://cn.bing.com/academic/profile?id=378bcee1ab701a3ba6db9c2f343e322e&encoded=0&v=paper_preview&mkt=zh-cn
|
| [9] |
Quentin S, Cuccuini W, Ceccaldi R, et al. Myelodysplasia and leukemia of fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions[J]. Blood, 2011, 117(15): e161-70. doi: 10.1182/blood-2010-09-308726
|
| [10] |
Mehta PA, Harris RE, Davies SM, et al. Numerical chromosomal changes and risk of development of myelodysplastic syndrome-acute myeloid leukemia in patients with fanconi anemia[J]. Cancer Genet Cytogenet, 2010, 203(2): 180-6. doi: 10.1016/j.cancergencyto.2010.07.127
|
| [11] |
Chirnomas SD, Kupfer GM. The inherited bone marrow failure syndromes[J]. Pediatr Clin North Am, 2013, 60(6): 1291-5. doi: 10.1016/j.pcl.2013.09.007
|
| [12] |
Macmillan ML, Wagner JE. Haematopoeitic cell transplantation for fanconi anaemia-when and how[J]. Br J Haematol, 2010, 149(1):14-21. doi: 10.1111/bjh.2010.149.issue-1
|
| [13] |
Benajiba L, Salvado C, Dalle J, et al. HLA-matched related-donor HSCT in fanconi anemia patients conditioned with cyclophosphamide and fludarabine[J]. Blood, 2015, 125(2): 417-8. doi: 10.1182/blood-2014-10-605113
|
| [14] |
Mitchell R, Wagner JE, Hirsch B, et al. Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in fanconi anaemia[J]. Br J Haematol, 2014, 164(3):384-95. doi: 10.1111/bjh.2014.164.issue-3
|
| [15] |
Talbot A, de Latour RP, Raffoux EA, et al. Sequential treatment for allogeneic hematopoietic stem cell transplantation in fanconi anemia with acute myeloid leukemia[J]. Haematologica, 2014, 99(10): E199-200. doi: 10.3324/haematol.2013.098954
|
| [16] |
Donahue RE, Tuschong L, Bauer J, et al. Leukocyte integrin activation mediates transient neutropenia after G-CSF administration[J]. Blood, 2011, 118(15): 4209-14. doi: 10.1182/blood-2011-06-360461
|
| [17] |
Rose SR, Kim MO, Korbee L, et al. Oxandrolone for the treatment of bone marrow failure in fanconi anemia[J]. Pediatr Blood Cancer,2014, 61(1): 11-9. doi: 10.1002/pbc.v61.1
|
| [18] |
Fernández MS, Teruya FJ. The diagnosis and treatment of dyskeratosis congenita:a review[J]. J Blood Med, 2014(5): 157-67. http://cn.bing.com/academic/profile?id=29b62766f851f7b7d3ebdb126aa8f533&encoded=0&v=paper_preview&mkt=zh-cn
|
| [19] |
Sinha S, Trivedi V, Krishna A, et al. Dyskeratosis congenital management and review of complications:a case report[J]. Oman Med J, 2013, 28(4): 281-4. doi: 10.5001/omj.2013.78
|
| [20] |
Karunakaran A, Ravindran R, Arshad M, et al. Dyskeratosis congenita:a report of two cases[J]. Case Rep Dent, 2013,12(8):125-31. http://cn.bing.com/academic/profile?id=b1b4e94428dc35092f9a1c27441d5dba&encoded=0&v=paper_preview&mkt=zh-cn
|
| [21] |
Nelson ND, Bertuch AA. Dyskeratosis congenita as a disorder of telomere maintenance[J]. Mutat Res, 2012, 730(2): 43-51.
|
| [22] |
Dokal I. Dyskeratosis congenita[J]. Hematology Am Soc Hematol Educ Program, 2011,17(2): 480-6.
|
| [23] |
Dokal I, Vulliamy T, Mason P, et al. Clinical utility gene card for: dyskeratosis congenita[J]. Eur J Hum Genet, 2011, 19(11): 1-11. http://cn.bing.com/academic/profile?id=fe0bd83cc256c6a2d42f509ea31fa6e2&encoded=0&v=paper_preview&mkt=zh-cn
|
| [24] |
Parry EM, Alder JK, Lee SS, et al. Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita[J]. J Med Genet, 2011, 48(5): 327-33. doi: 10.1136/jmg.2010.085100
|
| [25] |
Nishio N, Kojima S. Recent progress in dyskeratosis congenita[J]. Int J Hematol, 2010, 92(3): 419-24. doi: 10.1007/s12185-010-0695-5
|
| [26] |
Islam A, Rafiq S, Kirwan M, et al. Haematological recovery in dyskeratosis congenita patients treated with danazol[J]. Br J Haematol, 2013, 162(6): 854-6. doi: 10.1111/bjh.2013.162.issue-6
|
| [27] |
Ballew BJ, Yeager M, Jacobs K, et al. Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita[J]. Hum Genet, 2013, 132(4): 473-80. doi: 10.1007/s00439-013-1265-8
|
| [28] |
Gadalla SM, Sales BC, Carreras J, et al. Outcomes of allogeneic hemato-poietic cell transplantation in patients with dyskeratosis congenita[J]. Biol Blood Marrow Transplant, 2013, 19(8): 1238-43. doi: 10.1016/j.bbmt.2013.05.021
|
| [29] |
Savage SA, Bertuch AA. The genetics and clinical manifestations of telomere biology disorders[J]. Genet Med, 2010, 12(12): 753-64. doi: 10.1097/GIM.0b013e3181f415b5
|
| [30] |
Josephs HW. Anaemia of infancy and early childhood[J]. Medicine,1936,15(8): 307-10. http://cn.bing.com/academic/profile?id=ddb4ecf4da22da15a621164deecf86a4&encoded=0&v=paper_preview&mkt=zh-cn
|
| [31] |
Horos R, von Lindern M. Molecular mechanisms of pathology and treatment in diamond blackfan anaemia[J]. Br J Haematol, 2012,159(5): 514-27. http://cn.bing.com/academic/profile?id=1eefe9053b6adc6543d66504997d2339&encoded=0&v=paper_preview&mkt=zh-cn
|
| [32] |
Willig TN, Gazda H, Sieff CA. Diamond-blackfan anemia[J]. Curr Opin Hemato, 2000, 7(2): 85-94. doi: 10.1097/00062752-200003000-00003
|
| [33] |
Janov AJ, Leong T, Nathan DG, et al. Diamond-blackfan anemia[J]. Natural history and sequelae of treatment[J]. Medicine(Baltimore), 1996, 75(2): 77-8.
|
| [34] |
van Dijken PJ, Verwijs W. Diamond-blackfan anemia and malignancy: a case report and a review of the literature[J]. Cancer,1995, 76(3): 517-20. doi: 10.1002/(ISSN)1097-0142
|
| [35] |
Gerrard G, Valganon M, Foong HE, et al. Target enrichment and High-Throughput sequencing of 80 ribosomal protein genes to identify mutations associated with Diamond-blackfan anaemia[J]. Br J Haematol, 2012, 120(21): 530-6. http://cn.bing.com/academic/profile?id=721187132c321856a37d6b9bb3090031&encoded=0&v=paper_preview&mkt=zh-cn
|
| [36] |
Boria I, Garelli E, Gazda HT, et al. The ribosomal basis of Diamond-blackfan anemia: mutation and database update[J]. Hum Mutat, 2010, 31(12): 1269-79. doi: 10.1002/humu.21383
|
| [37] |
Gazda HT, Sheen MR, Vlachos A, et al. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients[J]. Am J Hum Genet, 2008,83(6): 769-80. doi: 10.1016/j.ajhg.2008.11.004
|
| [38] |
Quarello P, Garelli E, Carando A, et al. Diamond-blackfan anemia: genotype-phenotype correlations in Italian patients with RPL5 and RPL11 mutations[J]. Haematologica, 2010, 95(2): 206-13. doi: 10.3324/haematol.2009.011783
|
| [39] |
Muaishima H, Ohga S, Ohara A, et al. Hematopoietic stem cell transplantation for Diamond-blackfan anemia: a report from the aplastic anemia committee of the Japanese society of pediatric hematology[J]. Pediatr Transplant, 2007, 11(6): 601-7. http://cn.bing.com/academic/profile?id=6cebd3b14ffa287a3275d38d5af26920&encoded=0&v=paper_preview&mkt=zh-cn
|
| [40] |
Peffault LR, Peters C, Gibson B, et al. Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes[J]. Bone Marrow Transplant, 2015, 50(9):1168-72. doi: 10.1038/bmt.2015.117
|
| [41] |
Shwachman H, Diamond LK, Oski F, et al. The syndrome of pancreatic insufficiency and bone marrow dysfunction[J]. J Pediatr,1964, 65(8): 645-63. http://cn.bing.com/academic/profile?id=e6af0c7aee646d401e8a4085ca349eab&encoded=0&v=paper_preview&mkt=zh-cn
|
| [42] |
Kawakami T, Mitsui T, Kanai M, et al. Genetic analysis of Shwachman-Diamond syndrome: Phenotypic heterogeneity in patients carrying identical SBDS mutations[J]. J Exp Med, 2005,206(3): 253-9. http://cn.bing.com/academic/profile?id=2b7dc163317168ea656b585e71c9f120&encoded=0&v=paper_preview&mkt=zh-cn
|
| [43] |
Dall'oca C, Bondi M, Merlini M, et al. Shwachman-diamond syndrome[J]. Musculoskelet Surg, 2012, 96(2): 81-8. doi: 10.1007/s12306-011-0174-z
|
| [44] |
Dror Y. Shwachman-Diamond syndrome(review)[J].Pediatric Blood Cancer, 2005, 45(7): 892-901. doi: 10.1002/(ISSN)1545-5017
|
| [45] |
Donadieu J, Leblanc T, Bader MB, et al. Analysis of risk factors for myelodysplasias,leukemias and death from infection among patients with congenital neutropenia[J].Haematologica, 2005, 90(1): 45-53.
|
| [46] |
Minelli A, Maserati E, Nicolis E, et al. The isochromosome i(7)(q10)carrying c.258t2t>c mutation of the SBDS gene does not promote development of myeloid malignancies in patients with Shwachman syndrome[J]. Leukemia, 2009, 23(4): 708-11. doi: 10.1038/leu.2008.369
|
| [47] |
Bizzetto R, Bonfim C, Rocha V, et al. Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia [J]. Haematologica, 2011, 96(1): 134-41. doi: 10.3324/haematol.2010.027839
|
| [48] |
Cesaro S, Oneto R, Messina C, et al. Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation[J]. Br J Haematol, 2005, 131(2): 231-6. doi: 10.1111/bjh.2005.131.issue-2
|
| [49] |
Donadieu J, Michel G, Merlin E, et al. Hematopoietic stem cell transplantation for Shwachman-diamond syndrome: experience of the French neutropenia registry[J]. Bone Marrow Transplant, 2005,36(9): 787-92. doi: 10.1038/sj.bmt.1705141
|
| [50] |
Bonilla M, Gillio AP, Ruggeiro M, et al. Effects of recombinant human granulocyte colony-stimulating factor onneutropenia in patients with congenital agranulocytosis[J]. N Engl J Med, 1989,320(2): 1574-80.
|
| [51] |
Boztug K, Klein C. Genetic etiologies of severe congenital neutropenia[J]. Curr Opin Pediatr, 2011, 23(1): 21-6. doi: 10.1097/MOP.0b013e32834262f8
|
| [52] |
Ferry C, Ouachee M, Leblanc T, et al. Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register[J]. Bone Marrow Transplant, 2005, 35(1):45-50. doi: 10.1038/sj.bmt.1704718
|
| [53] |
Pasquet M, Bellanne C, Tavitian S, et al. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia[J]. Blood, 2013, 121(5): 822-9. doi: 10.1182/blood-2012-08-447367
|
| [54] |
Connelly JA, Choi SW, Levine JE. Hematopoietic stem cell transplantation for severe congenital neutropenia[J]. Curr Opin Hematol, 2012, 19(1): 44-51. doi: 10.1097/MOH.0b013e32834da96e
|
| [55] |
Ballmaier M, Germeshausen M. Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis and treatment[J]. Semin Thromb Hemost, 2011, 37(6): 673-81. doi: 10.1055/s-0031-1291377
|
| [56] |
Stoddart MT, Connor P, Germeshausen MA, et al. Congenital amegakaryocytic thrombocytopenia (CAMT) presenting as severe pancytopenia in the first month of Life[J]. Pediatr Blood Cancer,2013, 60(9): E94-6. doi: 10.1002/pbc.v60.9
|
| [57] |
Fahd M, Dalissier A, Alahmari AA, et al. Allogeneic stem cell transplantation in amegacaryocytosis:results of a retrospective study in EBMT centers[J]. Oral presentation, 2014, 30(4): 156-63.
|
| [58] |
Fadoo Z, Naqvi SM. Acute myeloid leukemia in a patient with thrombocytopeniawith absent radii syndrome[J]. J Pediatr Hematol Oncol, 2002, 24(2): 134-5. doi: 10.1097/00043426-200202000-00015
|
| [59] |
Go RS, Johnston KL. Acute myelogenous leukemia in an adult with thrombocytopenia with absent radii syndrome[J]. Eur J Haematol, 2003, 70(4): 246-8. doi: 10.1034/j.1600-0609.2003.00054.x
|
点击查看大图
下载:
